GRAMPUS-CF: Understanding gut symptoms in people with CF
Details
- Therapeutic approach
- Nutritional-GI
- Trial status
- Open to recruitment Participating Centres
- Trials Tracker ID
- TT013986
- Last updated
- 19/01/2024
A study to understand different patterns of gut symptoms in people with CF and what causes them
Study detailsOne of the top research priorities in the CF community is:
How can we relieve gastrointestinal (GI) symptoms such as stomach pain, bloating and nausea in people with CF?
To help answer this question, we need to understand the different patterns of symptoms that may occur in people with CF and what goes wrong in the body to cause these symptoms (we call this the ‘mechanism’). If we understand this correctly, we can choose treatments that are likely to help relieve symptoms and test these in clinical trials.
There will be two parts to the study: Part 1 and Part 2.
In this Part 1, researchers will observe diet and gut symptoms by asking you to complete questionnaires and give blood and stool (poo) samples at the beginning of the study, after 6 months, and after 12 months. They will use these to assess things like the gut microbiome (germs found in poo) and gut inflammation. Some people will also be asked to have a magnetic resonance imaging (MRI) scan of the abdomen. Part 1 has now concluded.
In Part 2, researchers will observe diet and gut symptoms by asking you to complete questionnaires at the beginning of the study, after 6 months, and after 12 months.
This study is being run by a Strategic Research Centre (SRC), funded by Cystic Fibrosis Trust, known as GRAMPUS-CF: Gut Research Advancing a Mechanistic and Personalised Understanding of Symptoms in Cystic Fibrosis.
Find out more about the GRAMPUS-CF SRC here.
- Phase
- Not applicable
- Length of participation
- 12 months
- Recruitment target
- 350
- CF sponsor
- The University of Nottingham
- CF sponsor type
- Academic
Who can take part?
- Age range
- Aged 6 years and older
- Including people
- People with confirmed cystic fibrosis aged 6 years and older attending Nottingham and Leeds adult and children's CF Centres
-
Remote participation via app is available for people with CF aged 12 years and older attending any CF clinic. Please visit our webpage for instructions on how to take part: Join the study - take part in GRAMPUS-CF via the app — GRAMPUS-CF

- Excluding people
- With a diagnosis of an additional gastrointestinal condition e.g. inflammatory bowel disease, coeliac disease, or gastrointestinal cancer
- Who are pregnant
- Remote participation
- Remote participation is possible for this trial